We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+2.84%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$37.8B
AUM Growth
+$858M
Cap. Flow
+$54.1M
Cap. Flow %
0.14%
Top 10 Hldgs %
5.01%
Holding
2,954
New
116
Increased
1,159
Reduced
1,473
Closed
125

Top Buys

Rank Stock Value
1
IT icon
Gartner
IT
+$57.5M
2
ALGN icon
Align Technology
ALGN
+$53.5M
3
DXC icon
DXC Technology
DXC
+$51.9M
4
ANSS
Ansys
ANSS
+$46.1M
5
EG icon
Everest Group
EG
+$34.5M

Sector Composition

Rank Sector Weight
1 Technology 13.9%
2 Financials 12.99%
3 Healthcare 12.28%
4 Industrials 11.03%
5 Consumer Discretionary 10.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SJR
1076
DELISTED
Shaw Communications Inc.
SJR
$4.53M 0.01%
207,695
+24,784
+14% +$533K
CPA icon
1077
Copa Holdings
CPA
$5.56B
$4.53M 0.01%
38,679
-10,995
-22% -$1.27M
LII icon
1078
Lennox International
LII
$15B
$4.52M 0.01%
24,610
-1,440
-6% -$251K
WPM icon
1079
Wheaton Precious Metals
WPM
$49.7B
$4.51M 0.01%
226,575
-16,596
-7% -$339K
MFA
1080
MFA Financial
MFA
$932M
$4.47M 0.01%
133,113
-78,668
-37% -$2.6M
AGO icon
1081
Assured Guaranty
AGO
$3.73B
$4.46M 0.01%
106,919
-179,104
-63% -$7.06M
AEM icon
1082
Agnico Eagle Mines
AEM
$72.2B
$4.46M 0.01%
98,874
-20,441
-17% -$960K
WSM icon
1083
Williams-Sonoma
WSM
$27.5B
$4.45M 0.01%
183,354
-3,922
-2% -$100K
NBIX icon
1084
Neurocrine Biosciences
NBIX
$18.2B
$4.44M 0.01%
96,485
+7,720
+9% +$374K
SPTN
1085
DELISTED
SpartanNash
SPTN
$4.43M 0.01%
170,508
-4,200
-2% -$138K
HYEM icon
1086
VanEck Emerging Markets High Yield Bond ETF
HYEM
$522M
$4.42M 0.01%
180,177
+13,240
+8% +$327K
ING icon
1087
ING
ING
$92.9B
$4.42M 0.01%
253,809
-20,006
-7% -$329K
PKO
1088
DELISTED
Pimco Income Opportunity Fund
PKO
$4.41M 0.01%
164,072
-41,190
-20% -$1.07M
LBRDK icon
1089
Liberty Broadband Class C
LBRDK
$4.89B
$4.39M 0.01%
50,580
+2,523
+5% +$221K
EPD icon
1090
Enterprise Products Partners
EPD
$83.7B
$4.37M 0.01%
161,488
-86,877
-35% -$2.35M
NTRI
1091
DELISTED
NutriSystem, Inc.
NTRI
$4.37M 0.01%
83,966
-3,440
-4% -$178K
SVC
1092
Service Properties Trust
SVC
$1.05B
$4.37M 0.01%
29,976
+1,060
+4% +$162K
JUNO
1093
DELISTED
Juno Therapeutics, Inc.
JUNO
$4.35M 0.01%
145,663
-5,367
-4% -$132K
CMTL icon
1094
Comtech Telecommunications
CMTL
$49.7M
$4.34M 0.01%
228,817
-60,266
-21% -$932K
PCK
1095
DELISTED
Pimco California Municipal Income Fund II
PCK
$4.33M 0.01%
425,714
-49,091
-10% -$495K
ETD icon
1096
Ethan Allen Interiors
ETD
$600M
$4.32M 0.01%
133,708
+29,818
+29% +$877K
BGC icon
1097
BGC Group
BGC
$5.64B
$4.31M 0.01%
530,847
-39,544
-7% -$296K
MDC
1098
DELISTED
M.D.C. Holdings, Inc.
MDC
$4.31M 0.01%
153,807
-32,570
-17% -$853K
SWBI icon
1099
Smith & Wesson
SWBI
$649M
$4.29M 0.01%
+251,907
New +$4.34M
CMRE icon
1100
Costamare
CMRE
$1.85B
$4.28M 0.01%
586,000
-82,008
-12% -$574K

Similar funds

Guggenheim Capital's Q2 2017 Portfolio in Review

As of Q2 2017, Guggenheim Capital held 2,954 positions worth $37.8B, up 2.3% from $36.9B the previous quarter. Its ten largest holdings account for 5% of the portfolio.

Guggenheim Capital's Q2 2017 filing shows 116 new, 1,159 increased, 1,473 reduced and 125 closed positions. Its largest new stake was DXC Technology: 781,396 shares worth $51.9M. The largest sale was Yahoo Inc, an estimated $55.8M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

  • Guggenheim Capital's largest Q2 2017 buy was DXC Technology: 781,396 shares worth $51.9M.
  • Guggenheim Capital added most to Gartner in Q2 2017, an estimated $57.5M increase.
  • Guggenheim Capital's biggest Q2 2017 reduction was Teradata, cutting an estimated $40.2M.
  • Guggenheim Capital fully exited Yahoo Inc in Q2 2017, selling an estimated $55.8M.
  • Guggenheim Capital's ten largest holdings make up 5% of its $37.8B portfolio in Q2 2017.
  • Guggenheim Capital opened 116 new positions and closed 125 in Q2 2017.
  • Guggenheim Capital's portfolio value rose 2.3% quarter-over-quarter to $37.8B.

Based on Guggenheim Capital's 13F filing for Q2 2017, filed 14 Aug 2017.